Vaga, Stefania
Lee, Sunjae
Ji, Boyang
Andreasson, Anna
Talley, Nicholas J.
Agréus, Lars
Bidkhori, Gholamreza
Kovatcheva-Datchary, Petia
Park, Junseok
Lee, Doheon
Proctor, Gordon
Ehrlich, Stanislav Dusko
Nielsen, Jens
Engstrand, Lars
Shoaie, Saeed
Funding for this research was provided by:
National Health and Medical Research Council of Australia
President’s International Fellowship Initiative (Project No. 2018PB0028)
DICP Outstanding Postdoctoral Foundation (2017YB05)
Bio-Synergy Research Project of the Ministry of Science and ICT through the National Research Foundation (2012M3A9C4048758)
Metagenopolis (ANR-11-DPBS-0001)
T. Söderbergs foundation
Engineering and Physical Sciences Research Council
Biotechnology and Biological Sciences Research Council (project EP/ S001301/1)
Article History
Received: 23 January 2020
Accepted: 17 August 2020
First Online: 11 September 2020
Competing interests
: N.J.T. reports personal fees from Allergans PLC (GI Development Programs) , personal fees from Viscera Labs (IBS), personal fees from IM Health Sciences (FD), personal fees from Napo Pharmaceutical (IBS), personal fees from Outpost Medicine (IBS), from ProgenityInc San Diego (capsule SIBO), from Allakos (gastric eosinophilic disease), personal fees from Samsung Bioepis (IBD), personal fees from Synergy (IBS), personal fees from Takeda (gastroparesis), personal fees from Theravance (gastroparesis), grants and personal fees from Viscera USA (IBS), grants from Commonwealth Diagnostics (International) Inc (IBS), non-financial support from HVN National Science Challenge NZ (IBS), grants and personal fees from GI therapies (constipation), personal fees from Cadila Pharmaceuticals (CME), personal fees from Planet Innovation (Gas capsule), personal fees from Danone (Probiotic), personal fees from Pfizer (IBS), from Dr. Reddy's Laboratories (Webinar), personal fees from Arlyx (IBS), personal fees from Sanofi (Probiotic), outside the submitted work; In addition, Dr. Talley has a patent Biomarkers of IBS licensed, a patent Licensing Questionnaires Talley Bowel Disease Questionnaires licensed to Mayo/Talley, a patent Nestec European Patent licensed, a patent Singapore Provisional Patent “Microbiota Modulation Of BDNF Tissue Repair Pathway” issued, and a patent Nepean Dyspepsia Index licensed to Talley copyright and Committees: Australian Medical Council (AMC) [Council Member]; Australian Telehealth Integration Programme; MBS Review Taskforce; NHMRC Principal Committee (Research Committee) Asia Pacific Association of Medical Journal Editors. Boards: GESA Board Member, Sax Institute, Committees of the Presidents of Medical Colleges. Community group: Advisory Board, IFFGD (International Foundation for Functional GI Disorders). Miscellaneous: Avant Foundation (judging of research grants). Editorial: Medical Journal of Australia (Editor in Chief), Up to Date (Section Editor), Precision and Future Medicine, Sungkyunkwan University School of Medicine, South Korea. All the other authors have no conflict of interests to declare.